BridgeMD
Tests treatment safety and results for Epilepsies, Partial
Official title Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
ClinicalTrials.gov ID: NCT06590896
What this study is testing
What is Cenobamate?
Cenobamate is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for epilepsies, partial.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- people completed Study YKP3089C035 by SK Life Science.
You likely can't join if
- people that have previously discontinued for any reason from the Core study (YKP3089C035).
- Any significant changes to the medical history of the subject that in the opinion of the investigator, could affect the safety of the subject.
The study team makes the final eligibility decision.
Where it's taking place
- Ehime, Japan
- Fukushima, Japan
- Hiroshima, Japan
- Hokkaido, Japan
- Hyōgo, Japan
- Ibaraki, Japan
- Kagoshima, Japan
- Kanagawa, Japan
- Kumamoto, Japan
- Nagasaki, Japan
- Osaka, Japan
- Saitama, Japan
- Shiga, Japan
- Shizuoka, Japan
- Tochigi, Japan
- Tokushima, Japan
- Tokyo, Japan
- Yamagata, Japan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ehime, Japan; Fukushima, Japan; Hiroshima, Japan; Hokkaido, Japan; Hyōgo, Japan; Ibaraki, Japan and 12 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.